Omeprazol Pharmazone (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Pharmazone, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal disorders in adults.

GNH USA supplies Omeprazol Pharmazone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive oesophagitis. - Peptic ulcer disease: facilitates ulcer healing and reduces recurrence risk. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics. - Zollinger‑Ellison syndrome: controls excessive gastric acid production in this rare endocrine disorder.

Omeprazole may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Diarrhoea: loose stools that usually resolve without intervention. - Nausea or abdominal discomfort: occasional stomach upset. - Flatulence or constipation: changes in bowel habits.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Low serum magnesium (hypomagnesemia): may cause muscle cramps, seizures, or cardiac arrhythmia. - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome): require immediate emergency care.

Before initiating therapy, consider the following safety measures.

- Assess liver function: dose adjustment may be needed in severe hepatic impairment. - Evaluate renal status: monitor electrolytes during long‑term use. - Use the lowest effective dose: limit duration to the shortest period necessary to achieve therapeutic goals. - Pregnancy and lactation: prescribe only if the potential benefit justifies the potential risk to the fetus or infant. - Elderly patients: monitor for increased risk of fractures and renal complications. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Omeprazole can alter the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect may increase cardiovascular risk. - Ketoconazole, itraconazole, atazanavir: decreased absorption due to higher gastric pH. - Warfarin: potential increase in INR, requiring closer monitoring.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels may necessitate dose adjustment. - Methotrexate (high‑dose): reduced clearance may raise toxicity risk.